Identification of stage IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.

被引：0
|
作者：
Wever, Renske
Tjien-Fooh, Felicia
Bellomo, Domenico
Quattrocchi, Enrica
Damodaran, Sindhuja Sominidi
Van Vliet, Martin
Dwarkasing, Jvalini
Meves, Alexander
Eggermont, Alexander M.
机构：
[1] SkylineDX BV, Rotterdam, Netherlands
[2] Mayo Clin, Rochester, MN USA
[3] Princess Maxima Ctr, Utrecht, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22088
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Improved risk assessment through incorporation of a prognostic 31-gene expression profile test for AJCC stage IB-IIA cutaneous melanoma
    Prado, Giselle
    Kurley, Sarah J.
    Covington, Kyle R.
    Cook, Robert W.
    Monzon, Federico A.
    Rigel, Darrell
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB224 - AB224
  • [22] Increased Frequency of Gene Mutations Significantly Decreases Recurrence Risk In High-Risk Stage II Melanoma Patients
    Dedeilia, Aikaterini
    Lwin, Thinzar
    Tunsiricharoengul, Sasha
    Boland, Genevieve M.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S86 - S87
  • [23] The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features
    Erdur, Erkan
    Yildirim, Ozgen Ahmet
    Poyraz, Kerem
    Aslan, Ferit
    Yildiz, Fatih
    Komek, Halil
    POSTGRADUATE MEDICINE, 2021, 133 (06) : 694 - 700
  • [24] Identification of patients at high risk for relapse using the Merlin Assay (CP-GEP) in an independent cohort of 451 patients (pts) with stage I/II melanoma who did not undergo sentinel lymph node biopsy
    Amaral, Teresa
    Chatziioannou, Eftychia
    Nuebling, Alica
    Nanz, Lena
    Sinnberg, Tobias
    Niessner, Heike
    Dwarkasing, Djvalini
    Arentsen, Tim
    Gross, Christian
    Eggermont, Alexander M.
    Leiter, Ulrike M.
    Flatz, Lukas
    Forchhammer, Stephan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Gene expression profiling for molecular identification of high-risk breast cancer patients
    Ahr, A
    Holtrich, U
    Solbach, C
    Scharl, A
    Strebhardt, K
    Karn, T
    Kaufmann, M
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2001, 61 (12) : 954 - 963
  • [26] Gene-expression profiling and identification of patients at high risk of breast cancer - Reply
    Ahr, A
    Karn, T
    Holtrich, U
    Kaufmann, M
    LANCET, 2002, 360 (9327): : 174 - 174
  • [27] Validation of a model combining clinicopathologic risk factors and a gene expression profile to identify primary melanoma patients who can safely forgo sentinel lymph node biopsy
    Meves, A.
    Yousaf, A. B.
    Tempel, D.
    Luna-Vargas, M.
    Chen, J.
    Dwarkasing, J.
    Kolodney, M. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S766 - S766
  • [28] Effect of gene expression profile (GEP) testing on clinical management in 19% of consecutively treated patients with stage IB/IIA melanoma at a single institution.
    Dengel, Lynn Thacher
    Hickman, Alexandra W.
    Slingluff, Craig L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Stereotactic Radiosurgery Results followed by Resection in Patients with large, high-risk stage Stage IIA-IIIB intraocular Choroidal Melanoma - A prospective Registry Study
    Guberina, M.
    Sokolenko, E.
    Guberina, N.
    Dalbah, S.
    Poettgen, C.
    Grunewald, T.
    Luebcke, W.
    Indenkaempen, F.
    Lachmuth, M.
    Fluehs, D.
    Chen, Y.
    Hoffmann, C.
    Jabbarli, L.
    Fiorentzis, M.
    Foerster, A.
    Rating, P.
    Ebenau, M.
    Bechrakis, N.
    Stuschke, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S132 - S132
  • [30] Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients
    Giampieri, Riccardo
    Scartozzi, Mario
    Loretelli, Cristian
    Piva, Francesco
    Mandolesi, Alessandra
    Lezoche, Giovanni
    Del Prete, Michela
    Bittoni, Alessandro
    Faloppi, Luca
    Bianconi, Maristella
    Cecchini, Luca
    Guerrieri, Mario
    Bearzi, Italo
    Cascinu, Stefano
    PLOS ONE, 2013, 8 (09):
12345